N-(Azetidin-3-yl)-2,2,2-trifluoroacetamide hydrochloride, 97%, 2.5g

4-Bromo-4'-tert-butylbiphenyl>98.0%(GC)25g

3-BROMO-5-METHYLIMIDAZO[1,2-A]PYRAZINE, 95.0%, 250mg

Ceramic table (replaces the original table)

7-Chloroimidazo[1,2-c]pyrimidin-5(6H)-one, 95.0%, 1g

4-(3-Bromo-4-fluorophenyl)-3-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one, 98%, 500mg

5-(Bromomethyl)benzo[d]thiazole, 95.0%, 1g

5-(((4-Nitrobenzyl)oxy)carbonyl)-3,3a,4,5,6,7-hexahydro-[1,2,3]oxadiazolo[3,4-a]pyrazin-8-ium-3-olate, 98%, 250mg

4-(4-Methoxyphenyl)-1,2,3-thiadiazole, 95.0%, 1g

2-Chloro-4-methyl-3-nitropyridine>98.0%(GC)1g

2-Oxa-6-azaspiro[3.3]heptane oxalate, 95.0%, 25g

4-Ethoxy-2,3-difluorophenylacetic acid, 95.0%, 1g

4-(4-nitro-phenyl)-3-oxo-butyric acid ethyl ester, 97%, 250mg